With ever-blurring lines between the food and pharmaceutical space, the NutraIngredients team asked experts at our recent Probiota conference how they believe the microbiome space will develop in the future.
Swedish-based Carbiotix continues to build on its gut health testing activities, having closed its latest funding round, bringing the total raised to date at €1m over the past 4 years.
There is no link between dietary intake of minerals and the onset in later life of multiple sclerosis (MS), according to a US study that plays down the role of zinc and iron deficiencies.
Chr. Hansen applies its microbiome expertise in the pharma arena as the firm enters a collaboration with Lonza to produce live biotherapeutic (LBP) products that address a range of gastrointestinal and cardiovascular conditions.
The Norwegian Government is to allow commercial harvesting of Calanus finmarchicus, an ecologically sustainable omega-3 fatty acid source found in huge quantities in the Norwegian Sea.
The European Medicines Agency (EMA) confirms that omega-3 fatty acid medicines are not effective in preventing further cardiovascular problems in patients who have had a heart attack.
Google stand accused of cashing in on unproven dementia supplements by selling advertising to retailers of “brain supplements,” flouting the search engine giant’s own advert and promotion policies.
A combination of regulatory hurdles and growing consumer demand for more effective products means companies are looking for new ways to innovate with encapsulation technologies and delivery systems, say experts speaking to NutraIngredients.
Microbiome science is mature enough to enter the pharma field, according to the CEO of a microbiota-focused drug developer, who presented at Probiota Copenhagen earlier this month.
The Clinical Nutrition market is set to witness annual growth of over 8.1% to 2025, spurred in part by nutritional supplements as healthcare providers increasingly focus on prevention, according to new research by Global Market Insights (GMI).
Nutrition solutions for critically ill patients should not ignore the potential of modulating gut bacteria for health, say researchers who suggest current enteral feeding solutions do not support gut defences and the microbiome.
Medical nutrition terminology is not consistently defined - with frequent inconsistencies between definitions and regulations relating to specific terms and practices, warn researchers who argue that standardised terminology is needed.
Bacteria in our guts may be impacting human health and disease by telling host genes what to do, say researchers who have uncovered a new mechanism by which our microbiome communicates with and controls the DNA of our own cells.
Symrise will collaborate with Swedish probiotics firm Probi in a deal that targets the nutricosmetic sector with probiotic-based products that look to address sensitive and dry skin.
Expectant mothers need sufficient prenatal omega-3 intake to reduce the risk of preterm birth and ensure healthy development for their offspring, according to a DSM expert.
